3.0.0 863 2022-11-01T15:17:48Z 2022-11-01T15:17:48Z House HR 2019-01-30 116 [Congressional Record Volume 165, Number 19 (Wednesday, January 30, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. MATSUI:H.R. 863.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, clause, which 3 provides Congresswith the power to ``regulate commerce with foreign nations,and among the several states, and with the Indian tribes.''[Page H1337]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2019-01-30T14:04:05Z 2019-01-30 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-01-30 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-01-30 Introduced in House IntroReferral 1000 9 Library of Congress M001163 Rep. Matsui, Doris O. [D-CA-6] Doris Matsui D CA O. 6 N J000292 Rep. Johnson, Bill [R-OH-6] Bill Johnson R OH 6 2019-01-30 True C001067 Rep. Clarke, Yvette D. [D-NY-9] Yvette Clarke D NY D. 9 2019-02-06 False K000188 Rep. Kind, Ron [D-WI-3] RON KIND D WI 3 2019-02-07 False Health Child health Civil actions and liability Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Licensing and registrations Prescription drugs Retail and wholesale trades Health 00 2019-01-30 Introduced in House 2021-09-10T14:29:07Z DXM Abuse Prevention Act of 2019

This bill addresses the sale and distribution of dextromethorphan (DXM).

Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.

The bill also establishes restrictions on (1)the sale of over-the-counter drugs containing DXM, and (2)the distribution of bulk DXM.

]]> DXM Abuse Prevention Act of 2019 Display Title DXM Abuse Prevention Act of 2019 Short Title(s) as Introduced DXM Abuse Prevention Act of 2019 Introduced in House IH Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes. Introduced in House IH Introduced in House 2019-01-30T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr863ih/xml/BILLS-116hr863ih.xml 2019-01-30 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.